Meeting
2020 ASCO Virtual Scientific Program
Comprehensive analysis of KRAS variants in patients (pts) with pancreatic cancer (PDAC): Clinical/molecular correlations and real-world outcomes across standard therapies.
Authors
Andrew Eugene Hendifar
Samuel Oschin Cancer Center, Cedars-Sinai Medical Center, Los Angeles, CA
Andrew Eugene Hendifar , Edik Matthew Blais , Camille Ng , Dzung Thach , Jun Gong , Davendra Sohal , Vincent Chung , Vaibhav Sahai , Christos Fountzilas , Sameh Mikhail , Gary Gregory , Jonathan Robert Brody , Emily Lyons , Patricia DeArbeloa , Lynn McCormick Matrisian , Emanuel Petricoin III, Michael J. Pishvaian
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Track
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Sub Track
Pancreatic Cancer
Citation
J Clin Oncol 38: 2020 (suppl; abstr 4641)
DOI
10.1200/JCO.2020.38.15_suppl.4641
Abstract #
4641
Poster Bd #
249
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Prognostic indicators of KRAS G12X mutations in pancreatic cancer.
First Author: Bach Ardalan
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Clinical impact of KRAS mutations in metastatic pancreatic ductal adenocarcinoma (PDAC).
First Author: Carter Norton
Poster
2023 ASCO Annual Meeting
Molecular and clinical correlates of DSCR1 expression in pancreatic cancer (PDAC).
First Author: Francesca Battaglin
Poster
2024 ASCO Gastrointestinal Cancers Symposium
KRAS mutation status in the prediction of pancreatic tumor response after neoadjuvant systemic therapy and magnetic resonance-guided SBRT.
First Author: Amit Jethanandani